{"disease":{"id":"anesthesia","name":"anesthesia"},"drugs":{"marketed":[{"drug_id":"articaine","indication_name":"Local, Infiltrative, or Conductive Anesthesia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Septocaine","generic_name":"ARTICAINE","company_name":"","drug_phase":"marketed","molecular_target":"Sodium channel alpha subunits; brain (Types I, II, III)","drug_class":"Amide Local Anesthetic","quality_score":65,"revenue":null,"mechanism":"Articaine HCl blocks nerve impulses by increasing the threshold for electrical excitation, slowing nerve impulse propagation, and reducing the rate of rise of the action potential."},{"drug_id":"sevoflurane","indication_name":"Induction and maintenance of general anesthesia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"SEVOFLURANE","company_name":"","drug_phase":"marketed","molecular_target":"","drug_class":"General Anesthetic [EPC]","quality_score":18,"revenue":null,"mechanism":null},{"drug_id":"sevoflurane","indication_name":"Induction and maintenance of general anesthesia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"SEVOFLURANE","company_name":"","drug_phase":"marketed","molecular_target":"","drug_class":"General Anesthetic [EPC]","quality_score":18,"revenue":null,"mechanism":null},{"drug_id":"isoproterenol","indication_name":"Treatment of bronchospasm during anesthesia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"ISOPROTERENOL","company_name":"","drug_phase":"marketed","molecular_target":"beta-adrenergic receptors","drug_class":"Beta-adrenergic agonist","quality_score":80,"revenue":null,"mechanism":"Isoproterenol activates beta-adrenergic receptors without affecting alpha-adrenergic receptors."},{"drug_id":"cocaine-hydrochloride","indication_name":"Nasal Anesthesia for Diagnostic Procedures and Surgeries","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"COCAINE HYDROCHLORIDE","company_name":"","drug_phase":"marketed","molecular_target":"","drug_class":"","quality_score":18,"revenue":null,"mechanism":null},{"drug_id":"prilocaine-hydrochloride","indication_name":"Local anesthesia in dentistry","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"PRILOCAINE HYDROCHLORIDE","company_name":"","drug_phase":"marketed","molecular_target":"","drug_class":"","quality_score":15,"revenue":null,"mechanism":null},{"drug_id":"nalbuphine-hydrochloride","indication_name":"Supplement to Balanced Anesthesia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"NALBUPHINE HYDROCHLORIDE","company_name":"","drug_phase":"marketed","molecular_target":"kappa opioid receptors, mu opioid receptors","drug_class":"","quality_score":60,"revenue":null,"mechanism":"Nalbuphine activates kappa opioid receptors and blocks mu opioid receptors."},{"drug_id":"chembl-chembl650","indication_name":"Local or Regional Anesthesia for Surgery","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"METHYLPREDNISOLONE","company_name":"","drug_phase":"marketed","molecular_target":"","drug_class":"","quality_score":45,"revenue":null,"mechanism":"Bupivacaine blocks nerve impulses by increasing the threshold for electrical excitation, slowing propagation, and reducing the rate of rise of the action potential."},{"drug_id":"hydroxyzine-pamoate","indication_name":"Sedation for premedication and post-anesthesia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"HYDROXYZINE PAMOATE","company_name":"","drug_phase":"marketed","molecular_target":"","drug_class":"","quality_score":25,"revenue":null,"mechanism":null},{"drug_id":"mepivacaine-hydrochloride","indication_name":"Local anesthesia for dental procedures","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"MEPIVACAINE HYDROCHLORIDE","company_name":"","drug_phase":"marketed","molecular_target":"","drug_class":"","quality_score":25,"revenue":null,"mechanism":null},{"drug_id":"chembl-chembl526","indication_name":"Induction of General Anesthesia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"PROPOFOL","company_name":"","drug_phase":"marketed","molecular_target":"","drug_class":"General Anesthetic [EPC]","quality_score":30,"revenue":null,"mechanism":null},{"drug_id":"chembl-chembl526","indication_name":"Maintenance of General Anesthesia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"PROPOFOL","company_name":"","drug_phase":"marketed","molecular_target":"","drug_class":"General Anesthetic [EPC]","quality_score":30,"revenue":null,"mechanism":null},{"drug_id":"chembl-chembl526","indication_name":"Sedation in Combination with Regional Anesthesia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"PROPOFOL","company_name":"","drug_phase":"marketed","molecular_target":"","drug_class":"General Anesthetic [EPC]","quality_score":30,"revenue":null,"mechanism":null},{"drug_id":"tetracaine","indication_name":"Topical ophthalmic anesthesia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Tetracaine Hydrochloride","generic_name":"TETRACAINE","company_name":"Alcon Labs","drug_phase":"marketed","molecular_target":"Sodium channel protein type 7 subunit alpha","drug_class":"Ester Local Anesthetic","quality_score":70,"revenue":null,"mechanism":"Tetracaine Hydrochloride works by blocking sodium channels in nerve cells to prevent pain signals from being transmitted."},{"drug_id":"lidocaine-and-prilocaine","indication_name":"Pretreatment for infiltration anesthesia on genital mucous membranes","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"lidocaine and prilocaine","company_name":"Dentsply International","drug_phase":"marketed","molecular_target":"","drug_class":"Amide Local Anesthetic [EPC]","quality_score":18,"revenue":null,"mechanism":null},{"drug_id":"alimemazine","indication_name":"General anesthesia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Temaril","generic_name":"alimemazine","company_name":"","drug_phase":"marketed","molecular_target":"Histamine H1 receptor","drug_class":"trimeprazine","quality_score":23,"revenue":null,"mechanism":""},{"drug_id":"levomenthol","indication_name":"Local anesthesia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Salonpas","generic_name":"LEVOMENTHOL","company_name":"","drug_phase":"marketed","molecular_target":"Transient receptor potential cation channel subfamily M member 8","drug_class":"Non-Standardized Plant Allergenic Extract [EPC]","quality_score":35,"revenue":null,"mechanism":""},{"drug_id":"sulfentanyl","indication_name":"General anesthesia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Sulfentanyl","company_name":"Shenzhen Third People's Hospital","drug_phase":"phase_1","molecular_target":"Solute carrier family 22 member 1, Delta-type opioid receptor, Kappa-type opioid receptor","drug_class":"","quality_score":32,"revenue":null,"mechanism":null},{"drug_id":"suxamethonium","indication_name":"General anesthesia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Succinylcholine Chloride","generic_name":"SUXAMETHONIUM","company_name":"Novartis","drug_phase":"marketed","molecular_target":"Muscle-type nicotinic acetylcholine receptor","drug_class":"Depolarizing Neuromuscular Blocker","quality_score":67,"revenue":null,"mechanism":"Succinylcholine Chloride works by mimicking the action of acetylcholine at the neuromuscular junction, causing a rapid depolarization of muscle fibers."},{"drug_id":"enflurane","indication_name":"General anesthesia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Efrane","generic_name":"ENFLURANE","company_name":"Baxter","drug_phase":"marketed","molecular_target":"Glycine receptor subunit alpha-1","drug_class":"General Anesthetic","quality_score":26,"revenue":null,"mechanism":""},{"drug_id":"ropivacaine","indication_name":"Anesthesia for cesarean section","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Naropin","generic_name":"ROPIVACAINE","company_name":"Fresenius Kabi","drug_phase":"marketed","molecular_target":"Sodium channel protein type 5 subunit alpha","drug_class":"Amide Local Anesthetic","quality_score":49,"revenue":null,"mechanism":""},{"drug_id":"ropivacaine","indication_name":"Local anesthesia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Naropin","generic_name":"ROPIVACAINE","company_name":"Fresenius Kabi","drug_phase":"marketed","molecular_target":"Sodium channel protein type 5 subunit alpha","drug_class":"Amide Local Anesthetic","quality_score":49,"revenue":null,"mechanism":""},{"drug_id":"ropivacaine","indication_name":"Regional Anesthesia for Labor Pain","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Naropin","generic_name":"ROPIVACAINE","company_name":"Fresenius Kabi","drug_phase":"marketed","molecular_target":"Sodium channel protein type 5 subunit alpha","drug_class":"Amide Local Anesthetic","quality_score":49,"revenue":null,"mechanism":""},{"drug_id":"ropivacaine","indication_name":"Regional Anesthesia for Postoperative Pain","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Naropin","generic_name":"ROPIVACAINE","company_name":"Fresenius Kabi","drug_phase":"marketed","molecular_target":"Sodium channel protein type 5 subunit alpha","drug_class":"Amide Local Anesthetic","quality_score":49,"revenue":null,"mechanism":""},{"drug_id":"ropivacaine","indication_name":"Regional Anesthesia for Surgery","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Naropin","generic_name":"ROPIVACAINE","company_name":"Fresenius Kabi","drug_phase":"marketed","molecular_target":"Sodium channel protein type 5 subunit alpha","drug_class":"Amide Local Anesthetic","quality_score":49,"revenue":null,"mechanism":""},{"drug_id":"acetadote","indication_name":"General anesthesia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Acetadote","company_name":"University of Texas Southwestern Medical Center","drug_phase":"marketed","molecular_target":"Cystine/glutamate transporter, Cytochrome c, Glutathione synthetase","drug_class":"","quality_score":19,"revenue":null,"mechanism":null},{"drug_id":"midazolam-hydrochloride","indication_name":"General anesthesia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Versed","generic_name":"Midazolam Hydrochloride","company_name":"Takeda Pharmaceutical Company Limited","drug_phase":"marketed","molecular_target":"GABA A receptor alpha-5/beta-2/gamma-2","drug_class":"Benzodiazepine","quality_score":58,"revenue":null,"mechanism":""},{"drug_id":"midazolam-hydrochloride","indication_name":"Local anesthesia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Versed","generic_name":"Midazolam Hydrochloride","company_name":"Takeda Pharmaceutical Company Limited","drug_phase":"marketed","molecular_target":"GABA A receptor alpha-5/beta-2/gamma-2","drug_class":"Benzodiazepine","quality_score":58,"revenue":null,"mechanism":""},{"drug_id":"midazolam-hydrochloride","indication_name":"Sedation as Adjunct to Anesthesia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Versed","generic_name":"Midazolam Hydrochloride","company_name":"Takeda Pharmaceutical Company Limited","drug_phase":"marketed","molecular_target":"GABA A receptor alpha-5/beta-2/gamma-2","drug_class":"Benzodiazepine","quality_score":58,"revenue":null,"mechanism":""},{"drug_id":"chlordiazepoxide","indication_name":"General anesthesia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Chlordiazepoxide Hydrochloride","generic_name":"CHLORDIAZEPOXIDE","company_name":"Bausch Health","drug_phase":"marketed","molecular_target":"Histamine H1 receptor","drug_class":"Benzodiazepine","quality_score":57,"revenue":null,"mechanism":""},{"drug_id":"chlordiazepoxide","indication_name":"Local anesthesia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Chlordiazepoxide Hydrochloride","generic_name":"CHLORDIAZEPOXIDE","company_name":"Bausch Health","drug_phase":"marketed","molecular_target":"Histamine H1 receptor","drug_class":"Benzodiazepine","quality_score":57,"revenue":null,"mechanism":""},{"drug_id":"rocuronium","indication_name":"General anesthesia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Zemuron","generic_name":"ROCURONIUM","company_name":"Fresenius Kabi","drug_phase":"marketed","molecular_target":"Acetylcholine receptor","drug_class":"Nondepolarizing Neuromuscular Blocker","quality_score":80,"revenue":null,"mechanism":"Zemuron works by blocking the action of acetylcholine at the neuromuscular junction, preventing muscle contraction."},{"drug_id":"midazolam","indication_name":"General anesthesia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Versed","generic_name":"midazolam","company_name":"Generic (originally Roche)","drug_phase":"marketed","molecular_target":"Multidrug resistance protein 1, Cytochrome P450 3A4, GABA A receptor alpha-3/beta-2/gamma-2","drug_class":"Benzodiazepine (short-acting)","quality_score":48,"revenue":null,"mechanism":""},{"drug_id":"midazolam","indication_name":"Local anesthesia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Versed","generic_name":"midazolam","company_name":"Generic (originally Roche)","drug_phase":"marketed","molecular_target":"Multidrug resistance protein 1, Cytochrome P450 3A4, GABA A receptor alpha-3/beta-2/gamma-2","drug_class":"Benzodiazepine (short-acting)","quality_score":48,"revenue":null,"mechanism":""},{"drug_id":"midazolam","indication_name":"Sedation as Adjunct to Anesthesia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Versed","generic_name":"midazolam","company_name":"Generic (originally Roche)","drug_phase":"marketed","molecular_target":"Multidrug resistance protein 1, Cytochrome P450 3A4, GABA A receptor alpha-3/beta-2/gamma-2","drug_class":"Benzodiazepine (short-acting)","quality_score":48,"revenue":null,"mechanism":""},{"drug_id":"mivacurium","indication_name":"General anesthesia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Mivacron","generic_name":"MIVACURIUM","company_name":"AbbVie","drug_phase":"marketed","molecular_target":"Acetylcholine receptor","drug_class":"Nondepolarizing Neuromuscular Blocker","quality_score":45,"revenue":null,"mechanism":""},{"drug_id":"mepivacaine","indication_name":"Administration of Regional Anesthesia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Carbocaine","generic_name":"MEPIVACAINE","company_name":"Eastman Kodak","drug_phase":"marketed","molecular_target":"Sodium channel protein type 1 subunit alpha","drug_class":"Amide Local Anesthetic","quality_score":51,"revenue":null,"mechanism":""},{"drug_id":"mepivacaine","indication_name":"Local anesthesia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Carbocaine","generic_name":"MEPIVACAINE","company_name":"Eastman Kodak","drug_phase":"marketed","molecular_target":"Sodium channel protein type 1 subunit alpha","drug_class":"Amide Local Anesthetic","quality_score":51,"revenue":null,"mechanism":""},{"drug_id":"mepivacaine","indication_name":"Local anesthesia, by infiltration","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Carbocaine","generic_name":"MEPIVACAINE","company_name":"Eastman Kodak","drug_phase":"marketed","molecular_target":"Sodium channel protein type 1 subunit alpha","drug_class":"Amide Local Anesthetic","quality_score":51,"revenue":null,"mechanism":""},{"drug_id":"bupivacaine","indication_name":"Anesthesia for cesarean section","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Bupivacaine Hydrochloride And Epinephrine","generic_name":"BUPIVACAINE","company_name":"Innocoll","drug_phase":"marketed","molecular_target":"Cytochrome P450 2D6","drug_class":"Amide Local Anesthetic","quality_score":69,"revenue":null,"mechanism":"Bupivacaine works by blocking nerve impulses to prevent pain signals from reaching the brain."},{"drug_id":"bupivacaine","indication_name":"Local Anesthesia for Ophthalmologic Procedure","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Bupivacaine Hydrochloride And Epinephrine","generic_name":"BUPIVACAINE","company_name":"Innocoll","drug_phase":"marketed","molecular_target":"Cytochrome P450 2D6","drug_class":"Amide Local Anesthetic","quality_score":69,"revenue":null,"mechanism":"Bupivacaine works by blocking nerve impulses to prevent pain signals from reaching the brain."},{"drug_id":"bupivacaine","indication_name":"Local anesthesia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Bupivacaine Hydrochloride And Epinephrine","generic_name":"BUPIVACAINE","company_name":"Innocoll","drug_phase":"marketed","molecular_target":"Cytochrome P450 2D6","drug_class":"Amide Local Anesthetic","quality_score":69,"revenue":null,"mechanism":"Bupivacaine works by blocking nerve impulses to prevent pain signals from reaching the brain."},{"drug_id":"bupivacaine","indication_name":"Regional Anesthesia for Labor Pain","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Bupivacaine Hydrochloride And Epinephrine","generic_name":"BUPIVACAINE","company_name":"Innocoll","drug_phase":"marketed","molecular_target":"Cytochrome P450 2D6","drug_class":"Amide Local Anesthetic","quality_score":69,"revenue":null,"mechanism":"Bupivacaine works by blocking nerve impulses to prevent pain signals from reaching the brain."},{"drug_id":"bupivacaine","indication_name":"Regional Anesthesia for Ophthalmologic Surgery","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Bupivacaine Hydrochloride And Epinephrine","generic_name":"BUPIVACAINE","company_name":"Innocoll","drug_phase":"marketed","molecular_target":"Cytochrome P450 2D6","drug_class":"Amide Local Anesthetic","quality_score":69,"revenue":null,"mechanism":"Bupivacaine works by blocking nerve impulses to prevent pain signals from reaching the brain."},{"drug_id":"bupivacaine","indication_name":"Regional Anesthesia for Postoperative Pain","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Bupivacaine Hydrochloride And Epinephrine","generic_name":"BUPIVACAINE","company_name":"Innocoll","drug_phase":"marketed","molecular_target":"Cytochrome P450 2D6","drug_class":"Amide Local Anesthetic","quality_score":69,"revenue":null,"mechanism":"Bupivacaine works by blocking nerve impulses to prevent pain signals from reaching the brain."},{"drug_id":"bupivacaine","indication_name":"Regional Anesthesia for Surgery","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Bupivacaine Hydrochloride And Epinephrine","generic_name":"BUPIVACAINE","company_name":"Innocoll","drug_phase":"marketed","molecular_target":"Cytochrome P450 2D6","drug_class":"Amide Local Anesthetic","quality_score":69,"revenue":null,"mechanism":"Bupivacaine works by blocking nerve impulses to prevent pain signals from reaching the brain."},{"drug_id":"glycopyrronium-bromide","indication_name":"General anesthesia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Cuvposa","generic_name":"GLYCOPYRRONIUM BROMIDE","company_name":"Shionogi","drug_phase":"marketed","molecular_target":"Muscarinic acetylcholine receptor M1","drug_class":"Anticholinergic","quality_score":62,"revenue":null,"mechanism":"Cuvposa works by blocking the action of a chemical called acetylcholine, which stimulates the muscarinic receptors in the body."},{"drug_id":"prilocaine","indication_name":"Local anesthesia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Citanest","generic_name":"PRILOCAINE","company_name":"","drug_phase":"marketed","molecular_target":"Sodium channel alpha subunits; brain (Types I, II, III)","drug_class":"Amide Local Anesthetic [EPC]","quality_score":35,"revenue":null,"mechanism":null},{"drug_id":"cocaine","indication_name":"Local anesthesia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Goprelto","generic_name":"COCAINE","company_name":"","drug_phase":"marketed","molecular_target":"Sodium-dependent dopamine transporter","drug_class":"cocaine","quality_score":47,"revenue":null,"mechanism":""},{"drug_id":"fentanyl-f2","indication_name":"General anesthesia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Fentanyl (F2)","company_name":"Oslo University Hospital","drug_phase":"marketed","molecular_target":"D(4) dopamine receptor, Solute carrier family 22 member 1, D(2) dopamine receptor","drug_class":"Synthetic opioid","quality_score":33,"revenue":null,"mechanism":""},{"drug_id":"fentanyl-f2","indication_name":"Local anesthesia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Fentanyl (F2)","company_name":"Oslo University Hospital","drug_phase":"marketed","molecular_target":"D(4) dopamine receptor, Solute carrier family 22 member 1, D(2) dopamine receptor","drug_class":"Synthetic opioid","quality_score":33,"revenue":null,"mechanism":""},{"drug_id":"fentanyl-f2","indication_name":"Regional Anesthesia for Postoperative Pain","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Fentanyl (F2)","company_name":"Oslo University Hospital","drug_phase":"marketed","molecular_target":"D(4) dopamine receptor, Solute carrier family 22 member 1, D(2) dopamine receptor","drug_class":"Synthetic opioid","quality_score":33,"revenue":null,"mechanism":""},{"drug_id":"fentanyl-f2","indication_name":"Regional Anesthesia for Surgery","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Fentanyl (F2)","company_name":"Oslo University Hospital","drug_phase":"marketed","molecular_target":"D(4) dopamine receptor, Solute carrier family 22 member 1, D(2) dopamine receptor","drug_class":"Synthetic opioid","quality_score":33,"revenue":null,"mechanism":""},{"drug_id":"chloral-hydrate","indication_name":"General anesthesia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Nycoton","generic_name":"CHLORAL HYDRATE","company_name":"","drug_phase":"discontinued","molecular_target":"","drug_class":"chloral hydrate","quality_score":null,"revenue":null,"mechanism":"Nycoton works by acting as a central nervous system depressant, slowing down brain activity to induce sleep or anesthesia."},{"drug_id":"fluroxene","indication_name":"General anesthesia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Fluoromar","generic_name":"FLUROXENE","company_name":"","drug_phase":"phase_2","molecular_target":"","drug_class":"fluroxene","quality_score":null,"revenue":null,"mechanism":"Fluoromar works by inducing unconsciousness and amnesia through its effects on the central nervous system."},{"drug_id":"felypressin","indication_name":"Local anesthesia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Octapressin","generic_name":"FELYPRESSIN","company_name":"","drug_phase":"phase_2","molecular_target":"Vasopressin V1a receptor","drug_class":"","quality_score":null,"revenue":null,"mechanism":"Octapressin works by binding to the vasopressin V1a receptor, which blocks pain signals to the brain."},{"drug_id":"cetylpyridinium","indication_name":"Local anesthesia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Ceepryn","generic_name":"CETYLPYRIDINIUM","company_name":"","drug_phase":"marketed","molecular_target":"Caspase-2","drug_class":"cetylpyridinium","quality_score":38,"revenue":null,"mechanism":""},{"drug_id":"doxapram","indication_name":"Post-Anesthesia Respiratory Depression","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Dopram","generic_name":"DOXAPRAM","company_name":"Hikma","drug_phase":"marketed","molecular_target":"Cytochrome P450 2D6","drug_class":"Respiratory Stimulant","quality_score":48,"revenue":null,"mechanism":""},{"drug_id":"rocuronium-bromide","indication_name":"General anesthesia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Rocuronium","generic_name":"Rocuronium Bromide","company_name":"Merck & Co.","drug_phase":"marketed","molecular_target":"Cholinergic receptors at the motor end-plate","drug_class":"Nondepolarizing neuromuscular blocking agent","quality_score":80,"revenue":null,"mechanism":"Rocuronium bromide competes for cholinergic receptors at the motor end-plate, antagonized by acetylcholinesterase inhibitors."},{"drug_id":"acetylcysteine","indication_name":"General anesthesia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Acetadote","generic_name":"Acetylcysteine","company_name":"Bristol-Myers Squibb","drug_phase":"marketed","molecular_target":"Glutathione levels; reactive metabolite of acetaminophen","drug_class":"Antidote","quality_score":62,"revenue":null,"mechanism":"Acetylcysteine reduces liver injury from acetaminophen overdose by maintaining glutathione levels or providing alternate conjugation substrate."},{"drug_id":"lorazepam","indication_name":"Sedation as Adjunct to Anesthesia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Ativan","generic_name":"lorazepam","company_name":"Generic (originally Wyeth/Pfizer)","drug_phase":"marketed","molecular_target":"GABA-A receptor alpha-1/beta-3/gamma-2, Fatty acid-binding protein, liver","drug_class":"Benzodiazepine [EPC]","quality_score":45,"revenue":null,"mechanism":""},{"drug_id":"pethidine","indication_name":"General anesthesia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"pethidine","company_name":"","drug_phase":"unknown","molecular_target":"Solute carrier family 22 member 1, Glutamate receptor ionotropic, NMDA 3A, Kappa-type opioid receptor","drug_class":"","quality_score":null,"revenue":null,"mechanism":null},{"drug_id":"pethidine","indication_name":"Local anesthesia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"pethidine","company_name":"","drug_phase":"unknown","molecular_target":"Solute carrier family 22 member 1, Glutamate receptor ionotropic, NMDA 3A, Kappa-type opioid receptor","drug_class":"","quality_score":null,"revenue":null,"mechanism":null},{"drug_id":"pethidine","indication_name":"Sedation as Adjunct to Anesthesia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"pethidine","company_name":"","drug_phase":"unknown","molecular_target":"Solute carrier family 22 member 1, Glutamate receptor ionotropic, NMDA 3A, Kappa-type opioid receptor","drug_class":"","quality_score":null,"revenue":null,"mechanism":null},{"drug_id":"bupivacain","indication_name":"Anesthesia for cesarean section","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Bupivacain","company_name":"Sisli Hamidiye Etfal Training and Research Hospital","drug_phase":"marketed","molecular_target":"5-hydroxytryptamine receptor 3A, Cytochrome P450 2D6, Potassium channel subfamily K member 3","drug_class":"","quality_score":19,"revenue":null,"mechanism":null},{"drug_id":"bupivacain","indication_name":"Local Anesthesia for Ophthalmologic Procedure","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Bupivacain","company_name":"Sisli Hamidiye Etfal Training and Research Hospital","drug_phase":"marketed","molecular_target":"5-hydroxytryptamine receptor 3A, Cytochrome P450 2D6, Potassium channel subfamily K member 3","drug_class":"","quality_score":19,"revenue":null,"mechanism":null},{"drug_id":"bupivacain","indication_name":"Local anesthesia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Bupivacain","company_name":"Sisli Hamidiye Etfal Training and Research Hospital","drug_phase":"marketed","molecular_target":"5-hydroxytryptamine receptor 3A, Cytochrome P450 2D6, Potassium channel subfamily K member 3","drug_class":"","quality_score":19,"revenue":null,"mechanism":null},{"drug_id":"bupivacain","indication_name":"Regional Anesthesia for Labor Pain","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Bupivacain","company_name":"Sisli Hamidiye Etfal Training and Research Hospital","drug_phase":"marketed","molecular_target":"5-hydroxytryptamine receptor 3A, Cytochrome P450 2D6, Potassium channel subfamily K member 3","drug_class":"","quality_score":19,"revenue":null,"mechanism":null},{"drug_id":"bupivacain","indication_name":"Regional Anesthesia for Ophthalmologic Surgery","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Bupivacain","company_name":"Sisli Hamidiye Etfal Training and Research Hospital","drug_phase":"marketed","molecular_target":"5-hydroxytryptamine receptor 3A, Cytochrome P450 2D6, Potassium channel subfamily K member 3","drug_class":"","quality_score":19,"revenue":null,"mechanism":null},{"drug_id":"bupivacain","indication_name":"Regional Anesthesia for Postoperative Pain","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Bupivacain","company_name":"Sisli Hamidiye Etfal Training and Research Hospital","drug_phase":"marketed","molecular_target":"5-hydroxytryptamine receptor 3A, Cytochrome P450 2D6, Potassium channel subfamily K member 3","drug_class":"","quality_score":19,"revenue":null,"mechanism":null},{"drug_id":"bupivacain","indication_name":"Regional Anesthesia for Surgery","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Bupivacain","company_name":"Sisli Hamidiye Etfal Training and Research Hospital","drug_phase":"marketed","molecular_target":"5-hydroxytryptamine receptor 3A, Cytochrome P450 2D6, Potassium channel subfamily K member 3","drug_class":"","quality_score":19,"revenue":null,"mechanism":null},{"drug_id":"desflurane","indication_name":"General anesthesia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Suprane","generic_name":"DESFLURANE","company_name":"Baxter","drug_phase":"marketed","molecular_target":"GABA-A receptor; anion channel","drug_class":"General Anesthetic [EPC]","quality_score":41,"revenue":null,"mechanism":""},{"drug_id":"diprivan","indication_name":"General anesthesia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Diprivan","company_name":"St. Antonius Hospital","drug_phase":"marketed","molecular_target":"Cytochrome P450 2C9, Fatty-acid amide hydrolase 1, Transient receptor potential cation channel subfamily V member 4","drug_class":"","quality_score":19,"revenue":null,"mechanism":null},{"drug_id":"diprivan","indication_name":"Sedation as Adjunct to Anesthesia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Diprivan","company_name":"St. Antonius Hospital","drug_phase":"marketed","molecular_target":"Cytochrome P450 2C9, Fatty-acid amide hydrolase 1, Transient receptor potential cation channel subfamily V member 4","drug_class":"","quality_score":19,"revenue":null,"mechanism":null},{"drug_id":"lignocaine","indication_name":"Local Anesthesia for Endotracheal Intubation","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Lignocaine","company_name":"University of Malaya","drug_phase":"marketed","molecular_target":"5-hydroxytryptamine receptor 3A, Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 4, Sodium channel protein type 10 subunit alpha","drug_class":"","quality_score":19,"revenue":null,"mechanism":null},{"drug_id":"lignocaine","indication_name":"Local Anesthesia for Ophthalmologic Procedure","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Lignocaine","company_name":"University of Malaya","drug_phase":"marketed","molecular_target":"5-hydroxytryptamine receptor 3A, Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 4, Sodium channel protein type 10 subunit alpha","drug_class":"","quality_score":19,"revenue":null,"mechanism":null},{"drug_id":"lignocaine","indication_name":"Local Anesthesia for Urethral Pain","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Lignocaine","company_name":"University of Malaya","drug_phase":"marketed","molecular_target":"5-hydroxytryptamine receptor 3A, Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 4, Sodium channel protein type 10 subunit alpha","drug_class":"","quality_score":19,"revenue":null,"mechanism":null},{"drug_id":"lignocaine","indication_name":"Local anesthesia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Lignocaine","company_name":"University of Malaya","drug_phase":"marketed","molecular_target":"5-hydroxytryptamine receptor 3A, Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 4, Sodium channel protein type 10 subunit alpha","drug_class":"","quality_score":19,"revenue":null,"mechanism":null},{"drug_id":"lignocaine","indication_name":"Regional Anesthesia for Ophthalmologic Surgery","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Lignocaine","company_name":"University of Malaya","drug_phase":"marketed","molecular_target":"5-hydroxytryptamine receptor 3A, Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 4, Sodium channel protein type 10 subunit alpha","drug_class":"","quality_score":19,"revenue":null,"mechanism":null},{"drug_id":"glycopyrrolate","indication_name":"General anesthesia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Glycopyrrolate","company_name":"Yonsei University","drug_phase":"marketed","molecular_target":"Muscarinic acetylcholine receptor M1, Muscarinic acetylcholine receptor M2, Muscarinic acetylcholine receptor M3","drug_class":"","quality_score":19,"revenue":null,"mechanism":null},{"drug_id":"ropivacain","indication_name":"Anesthesia for cesarean section","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Ropivacain","company_name":"University Hospital, Basel, Switzerland","drug_phase":"marketed","molecular_target":"Potassium channel subfamily K member 3, Sodium channel protein type 1 subunit alpha, Sodium channel protein type 10 subunit alpha","drug_class":"","quality_score":19,"revenue":null,"mechanism":null},{"drug_id":"ropivacain","indication_name":"Local anesthesia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Ropivacain","company_name":"University Hospital, Basel, Switzerland","drug_phase":"marketed","molecular_target":"Potassium channel subfamily K member 3, Sodium channel protein type 1 subunit alpha, Sodium channel protein type 10 subunit alpha","drug_class":"","quality_score":19,"revenue":null,"mechanism":null},{"drug_id":"ropivacain","indication_name":"Regional Anesthesia for Labor Pain","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Ropivacain","company_name":"University Hospital, Basel, Switzerland","drug_phase":"marketed","molecular_target":"Potassium channel subfamily K member 3, Sodium channel protein type 1 subunit alpha, Sodium channel protein type 10 subunit alpha","drug_class":"","quality_score":19,"revenue":null,"mechanism":null},{"drug_id":"ropivacain","indication_name":"Regional Anesthesia for Postoperative Pain","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Ropivacain","company_name":"University Hospital, Basel, Switzerland","drug_phase":"marketed","molecular_target":"Potassium channel subfamily K member 3, Sodium channel protein type 1 subunit alpha, Sodium channel protein type 10 subunit alpha","drug_class":"","quality_score":19,"revenue":null,"mechanism":null},{"drug_id":"ropivacain","indication_name":"Regional Anesthesia for Surgery","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Ropivacain","company_name":"University Hospital, Basel, Switzerland","drug_phase":"marketed","molecular_target":"Potassium channel subfamily K member 3, Sodium channel protein type 1 subunit alpha, Sodium channel protein type 10 subunit alpha","drug_class":"","quality_score":19,"revenue":null,"mechanism":null},{"drug_id":"acetylcystein","indication_name":"General anesthesia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Acetylcystein","company_name":"University Hospital, Strasbourg, France","drug_phase":"marketed","molecular_target":"Cystine/glutamate transporter, Cytochrome c, Glutathione synthetase","drug_class":"","quality_score":19,"revenue":null,"mechanism":null},{"drug_id":"naropine","indication_name":"Anesthesia for cesarean section","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Naropine","company_name":"Rigshospitalet, Denmark","drug_phase":"phase_1","molecular_target":"Potassium channel subfamily K member 3, Sodium channel protein type 1 subunit alpha, Sodium channel protein type 10 subunit alpha","drug_class":"","quality_score":null,"revenue":null,"mechanism":null},{"drug_id":"naropine","indication_name":"Local anesthesia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Naropine","company_name":"Rigshospitalet, Denmark","drug_phase":"phase_1","molecular_target":"Potassium channel subfamily K member 3, Sodium channel protein type 1 subunit alpha, Sodium channel protein type 10 subunit alpha","drug_class":"","quality_score":null,"revenue":null,"mechanism":null},{"drug_id":"naropine","indication_name":"Regional Anesthesia for Labor Pain","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Naropine","company_name":"Rigshospitalet, Denmark","drug_phase":"phase_1","molecular_target":"Potassium channel subfamily K member 3, Sodium channel protein type 1 subunit alpha, Sodium channel protein type 10 subunit alpha","drug_class":"","quality_score":null,"revenue":null,"mechanism":null},{"drug_id":"naropine","indication_name":"Regional Anesthesia for Postoperative Pain","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Naropine","company_name":"Rigshospitalet, Denmark","drug_phase":"phase_1","molecular_target":"Potassium channel subfamily K member 3, Sodium channel protein type 1 subunit alpha, Sodium channel protein type 10 subunit alpha","drug_class":"","quality_score":null,"revenue":null,"mechanism":null},{"drug_id":"naropine","indication_name":"Regional Anesthesia for Surgery","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Naropine","company_name":"Rigshospitalet, Denmark","drug_phase":"phase_1","molecular_target":"Potassium channel subfamily K member 3, Sodium channel protein type 1 subunit alpha, Sodium channel protein type 10 subunit alpha","drug_class":"","quality_score":null,"revenue":null,"mechanism":null},{"drug_id":"cisatracurium","indication_name":"General anesthesia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Nimbex","generic_name":"CISATRACURIUM","company_name":"AbbVie","drug_phase":"marketed","molecular_target":"Acetylcholine receptor","drug_class":"Nondepolarizing Neuromuscular Blocker","quality_score":63,"revenue":null,"mechanism":"Nimbex works by blocking the action of acetylcholine at the neuromuscular junction, preventing muscle contraction."},{"drug_id":"pecazine","indication_name":"General anesthesia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"pecazine","company_name":"","drug_phase":"unknown","molecular_target":"5-hydroxytryptamine receptor 6, FAD-linked sulfhydryl oxidase ALR, 5-hydroxytryptamine receptor 2A","drug_class":"","quality_score":null,"revenue":null,"mechanism":null},{"drug_id":"atracurium-besylate","indication_name":"General anesthesia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Atracurium","generic_name":"Atracurium Besylate","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Cholinergic receptor sites on motor end-plate","drug_class":"Nondepolarizing skeletal muscle relaxant","quality_score":68,"revenue":null,"mechanism":"Nondepolarizing skeletal muscle relaxant that competitively antagonizes acetylcholine at motor end-plate cholinergic receptors."},{"drug_id":"lidocaine-hydrochloride","indication_name":"Local Anesthesia for Endotracheal Intubation","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Lignospan Forte","generic_name":"Lidocaine Hydrochloride","company_name":"Fresenius Kabi","drug_phase":"marketed","molecular_target":"neuronal membrane ionic channels","drug_class":"local anesthetic, amide type","quality_score":68,"revenue":null,"mechanism":"Lidocaine stabilizes neuronal membrane by inhibiting ionic fluxes required for impulse initiation and conduction."},{"drug_id":"lidocaine-hydrochloride","indication_name":"Local Anesthesia for Ophthalmologic Procedure","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Lignospan Forte","generic_name":"Lidocaine Hydrochloride","company_name":"Fresenius Kabi","drug_phase":"marketed","molecular_target":"neuronal membrane ionic channels","drug_class":"local anesthetic, amide type","quality_score":68,"revenue":null,"mechanism":"Lidocaine stabilizes neuronal membrane by inhibiting ionic fluxes required for impulse initiation and conduction."},{"drug_id":"lidocaine-hydrochloride","indication_name":"Local Anesthesia for Urethral Pain","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Lignospan Forte","generic_name":"Lidocaine Hydrochloride","company_name":"Fresenius Kabi","drug_phase":"marketed","molecular_target":"neuronal membrane ionic channels","drug_class":"local anesthetic, amide type","quality_score":68,"revenue":null,"mechanism":"Lidocaine stabilizes neuronal membrane by inhibiting ionic fluxes required for impulse initiation and conduction."},{"drug_id":"lidocaine-hydrochloride","indication_name":"Local anesthesia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Lignospan Forte","generic_name":"Lidocaine Hydrochloride","company_name":"Fresenius Kabi","drug_phase":"marketed","molecular_target":"neuronal membrane ionic channels","drug_class":"local anesthetic, amide type","quality_score":68,"revenue":null,"mechanism":"Lidocaine stabilizes neuronal membrane by inhibiting ionic fluxes required for impulse initiation and conduction."},{"drug_id":"lidocaine-hydrochloride","indication_name":"Regional Anesthesia for Ophthalmologic Surgery","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Lignospan Forte","generic_name":"Lidocaine Hydrochloride","company_name":"Fresenius Kabi","drug_phase":"marketed","molecular_target":"neuronal membrane ionic channels","drug_class":"local anesthetic, amide type","quality_score":68,"revenue":null,"mechanism":"Lidocaine stabilizes neuronal membrane by inhibiting ionic fluxes required for impulse initiation and conduction."},{"drug_id":"ethyl-chloride","indication_name":"Local anesthesia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Chelen","generic_name":"ETHYL CHLORIDE","company_name":"","drug_phase":"discontinued","molecular_target":"","drug_class":"ethyl chloride","quality_score":null,"revenue":null,"mechanism":"Ethyl chloride works by blocking sodium channels in nerve cells, preventing the transmission of pain signals to the brain."},{"drug_id":"procaine","indication_name":"Local anesthesia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Isocain","generic_name":"PROCAINE","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"5-hydroxytryptamine receptor 3A","drug_class":"Amide Local Anesthetic [EPC]","quality_score":34,"revenue":null,"mechanism":""},{"drug_id":"aprobarbital","indication_name":"General anesthesia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Allonal","generic_name":"APROBARBITAL","company_name":"","drug_phase":"marketed","molecular_target":"","drug_class":"aprobarbital","quality_score":16,"revenue":null,"mechanism":""},{"drug_id":"bucricaine","indication_name":"Local anesthesia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"BUCRICAINE","company_name":"","drug_phase":"phase_2","molecular_target":"","drug_class":"bucricaine","quality_score":null,"revenue":null,"mechanism":"Bucricaine works by blocking sodium channels in nerve cells, preventing the transmission of pain signals."},{"drug_id":"flutoprazepam","indication_name":"Induction of general anesthesia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Restas","generic_name":"FLUTOPRAZEPAM","company_name":"","drug_phase":"phase_2","molecular_target":"","drug_class":"flutoprazepam","quality_score":null,"revenue":null,"mechanism":"Flutoprazepam works by enhancing the activity of the neurotransmitter gamma-aminobutyric acid (GABA) in the brain."},{"drug_id":"etomidate","indication_name":"General anesthesia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Amidate","generic_name":"ETOMIDATE","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Cytochrome P450 11B2, mitochondrial","drug_class":"General Anesthetic [EPC]","quality_score":46,"revenue":null,"mechanism":""},{"drug_id":"fentanyl","indication_name":"General anesthesia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Duragesic","generic_name":"fentanyl","company_name":"Johnson & Johnson (Janssen Pharmaceutica)","drug_phase":"marketed","molecular_target":"D(4) dopamine receptor, Solute carrier family 22 member 1, D(2) dopamine receptor","drug_class":"Synthetic opioid analgesic","quality_score":55,"revenue":null,"mechanism":"Synthetic opioid 50-100x more potent than morphine that binds mu-opioid receptors, providing potent analgesia and anesthesia."},{"drug_id":"fentanyl","indication_name":"Local anesthesia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Duragesic","generic_name":"fentanyl","company_name":"Johnson & Johnson (Janssen Pharmaceutica)","drug_phase":"marketed","molecular_target":"D(4) dopamine receptor, Solute carrier family 22 member 1, D(2) dopamine receptor","drug_class":"Synthetic opioid analgesic","quality_score":55,"revenue":null,"mechanism":"Synthetic opioid 50-100x more potent than morphine that binds mu-opioid receptors, providing potent analgesia and anesthesia."},{"drug_id":"fentanyl","indication_name":"Regional Anesthesia for Postoperative Pain","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Duragesic","generic_name":"fentanyl","company_name":"Johnson & Johnson (Janssen Pharmaceutica)","drug_phase":"marketed","molecular_target":"D(4) dopamine receptor, Solute carrier family 22 member 1, D(2) dopamine receptor","drug_class":"Synthetic opioid analgesic","quality_score":55,"revenue":null,"mechanism":"Synthetic opioid 50-100x more potent than morphine that binds mu-opioid receptors, providing potent analgesia and anesthesia."},{"drug_id":"fentanyl","indication_name":"Regional Anesthesia for Surgery","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Duragesic","generic_name":"fentanyl","company_name":"Johnson & Johnson (Janssen Pharmaceutica)","drug_phase":"marketed","molecular_target":"D(4) dopamine receptor, Solute carrier family 22 member 1, D(2) dopamine receptor","drug_class":"Synthetic opioid analgesic","quality_score":55,"revenue":null,"mechanism":"Synthetic opioid 50-100x more potent than morphine that binds mu-opioid receptors, providing potent analgesia and anesthesia."},{"drug_id":"levorphanol","indication_name":"General anesthesia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Levo-Dromoran","generic_name":"LEVORPHANOL","company_name":"Bausch Health","drug_phase":"marketed","molecular_target":"mu-opioid receptor","drug_class":"Opioid Agonist","quality_score":64,"revenue":null,"mechanism":"Levorphanol binds primarily to mu-opioid receptors to produce analgesia, with no ceiling effect for pain relief."},{"drug_id":"levorphanol","indication_name":"Local anesthesia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Levo-Dromoran","generic_name":"LEVORPHANOL","company_name":"Bausch Health","drug_phase":"marketed","molecular_target":"mu-opioid receptor","drug_class":"Opioid Agonist","quality_score":64,"revenue":null,"mechanism":"Levorphanol binds primarily to mu-opioid receptors to produce analgesia, with no ceiling effect for pain relief."},{"drug_id":"pethidin","indication_name":"General anesthesia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Pethidin","company_name":"Ain Shams University","drug_phase":"marketed","molecular_target":"Solute carrier family 22 member 1, Glutamate receptor ionotropic, NMDA 3A, Kappa-type opioid receptor","drug_class":"","quality_score":19,"revenue":null,"mechanism":null},{"drug_id":"pethidin","indication_name":"Local anesthesia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Pethidin","company_name":"Ain Shams University","drug_phase":"marketed","molecular_target":"Solute carrier family 22 member 1, Glutamate receptor ionotropic, NMDA 3A, Kappa-type opioid receptor","drug_class":"","quality_score":19,"revenue":null,"mechanism":null},{"drug_id":"pethidin","indication_name":"Sedation as Adjunct to Anesthesia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Pethidin","company_name":"Ain Shams University","drug_phase":"marketed","molecular_target":"Solute carrier family 22 member 1, Glutamate receptor ionotropic, NMDA 3A, Kappa-type opioid receptor","drug_class":"","quality_score":19,"revenue":null,"mechanism":null},{"drug_id":"naropeine","indication_name":"Anesthesia for cesarean section","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Naropeine","company_name":"University Hospital, Rouen","drug_phase":"phase_3","molecular_target":"Potassium channel subfamily K member 3, Sodium channel protein type 1 subunit alpha, Sodium channel protein type 10 subunit alpha","drug_class":"","quality_score":null,"revenue":null,"mechanism":null},{"drug_id":"naropeine","indication_name":"Local anesthesia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Naropeine","company_name":"University Hospital, Rouen","drug_phase":"phase_3","molecular_target":"Potassium channel subfamily K member 3, Sodium channel protein type 1 subunit alpha, Sodium channel protein type 10 subunit alpha","drug_class":"","quality_score":null,"revenue":null,"mechanism":null},{"drug_id":"naropeine","indication_name":"Regional Anesthesia for Labor Pain","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Naropeine","company_name":"University Hospital, Rouen","drug_phase":"phase_3","molecular_target":"Potassium channel subfamily K member 3, Sodium channel protein type 1 subunit alpha, Sodium channel protein type 10 subunit alpha","drug_class":"","quality_score":null,"revenue":null,"mechanism":null},{"drug_id":"naropeine","indication_name":"Regional Anesthesia for Postoperative Pain","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Naropeine","company_name":"University Hospital, Rouen","drug_phase":"phase_3","molecular_target":"Potassium channel subfamily K member 3, Sodium channel protein type 1 subunit alpha, Sodium channel protein type 10 subunit alpha","drug_class":"","quality_score":null,"revenue":null,"mechanism":null},{"drug_id":"naropeine","indication_name":"Regional Anesthesia for Surgery","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Naropeine","company_name":"University Hospital, Rouen","drug_phase":"phase_3","molecular_target":"Potassium channel subfamily K member 3, Sodium channel protein type 1 subunit alpha, Sodium channel protein type 10 subunit alpha","drug_class":"","quality_score":null,"revenue":null,"mechanism":null},{"drug_id":"remifentanyl","indication_name":"General anesthesia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Remifentanyl","company_name":"Kocaeli University","drug_phase":"marketed","molecular_target":"Mu-type opioid receptor, Mu-type opioid receptor","drug_class":"","quality_score":30,"revenue":null,"mechanism":null},{"drug_id":"remifentanyl","indication_name":"Local anesthesia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Remifentanyl","company_name":"Kocaeli University","drug_phase":"marketed","molecular_target":"Mu-type opioid receptor, Mu-type opioid receptor","drug_class":"","quality_score":30,"revenue":null,"mechanism":null},{"drug_id":"morphine","indication_name":"General anesthesia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"MS Contin","generic_name":"morphine sulfate","company_name":"Generic (multiple manufacturers)","drug_phase":"marketed","molecular_target":"Solute carrier family 22 member 1, Delta-type opioid receptor, Kappa-type opioid receptor","drug_class":"Opioid analgesic","quality_score":55,"revenue":null,"mechanism":"The prototypical opioid agonist that binds mu-opioid receptors in the CNS, providing potent analgesia and serving as the reference standard for all opioids."},{"drug_id":"morphine","indication_name":"Local anesthesia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"MS Contin","generic_name":"morphine sulfate","company_name":"Generic (multiple manufacturers)","drug_phase":"marketed","molecular_target":"Solute carrier family 22 member 1, Delta-type opioid receptor, Kappa-type opioid receptor","drug_class":"Opioid analgesic","quality_score":55,"revenue":null,"mechanism":"The prototypical opioid agonist that binds mu-opioid receptors in the CNS, providing potent analgesia and serving as the reference standard for all opioids."},{"drug_id":"morphine","indication_name":"Regional Anesthesia for Labor Pain","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"MS Contin","generic_name":"morphine sulfate","company_name":"Generic (multiple manufacturers)","drug_phase":"marketed","molecular_target":"Solute carrier family 22 member 1, Delta-type opioid receptor, Kappa-type opioid receptor","drug_class":"Opioid analgesic","quality_score":55,"revenue":null,"mechanism":"The prototypical opioid agonist that binds mu-opioid receptors in the CNS, providing potent analgesia and serving as the reference standard for all opioids."},{"drug_id":"morphine","indication_name":"Regional Anesthesia for Surgery","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"MS Contin","generic_name":"morphine sulfate","company_name":"Generic (multiple manufacturers)","drug_phase":"marketed","molecular_target":"Solute carrier family 22 member 1, Delta-type opioid receptor, Kappa-type opioid receptor","drug_class":"Opioid analgesic","quality_score":55,"revenue":null,"mechanism":"The prototypical opioid agonist that binds mu-opioid receptors in the CNS, providing potent analgesia and serving as the reference standard for all opioids."},{"drug_id":"epinephrine","indication_name":"Local anesthesia, by infiltration","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Epipen","generic_name":"epinephrine","company_name":"Pfizer Inc.","drug_phase":"marketed","molecular_target":"Alpha-1D adrenergic receptor","drug_class":"alpha-Adrenergic Agonist [EPC]","quality_score":80,"revenue":null,"mechanism":"Epipen works by stimulating the alpha-1D adrenergic receptor to rapidly increase heart rate, blood pressure, and bronchodilation."},{"drug_id":"articaine","indication_name":"Local anesthesia, by infiltration","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Septocaine","generic_name":"ARTICAINE","company_name":"","drug_phase":"marketed","molecular_target":"Sodium channel alpha subunits; brain (Types I, II, III)","drug_class":"Amide Local Anesthetic","quality_score":65,"revenue":null,"mechanism":"Articaine HCl blocks nerve impulses by increasing the threshold for electrical excitation, slowing nerve impulse propagation, and reducing the rate of rise of the action potential."},{"drug_id":"isoproterenol","indication_name":"Treatment of bronchospasm occurring during anesthesia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"ISOPROTERENOL","company_name":"","drug_phase":"marketed","molecular_target":"beta-adrenergic receptors","drug_class":"Beta-adrenergic agonist","quality_score":80,"revenue":null,"mechanism":"Isoproterenol activates beta-adrenergic receptors without affecting alpha-adrenergic receptors."},{"drug_id":"promethazine","indication_name":"General anesthesia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Phenergan","generic_name":"promethazine","company_name":"Generic (originally Wyeth/Pfizer)","drug_phase":"marketed","molecular_target":"Aldehyde oxidase, 5-hydroxytryptamine receptor 6, FAD-linked sulfhydryl oxidase ALR","drug_class":"Phenothiazine antihistamine/antiemetic","quality_score":35,"revenue":null,"mechanism":""},{"drug_id":"l-cysteine","indication_name":"General anesthesia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"L-cysteine","company_name":"Louisiana State University Health Sciences Center Shreveport","drug_phase":"marketed","molecular_target":"Cystine/glutamate transporter","drug_class":"Amino acid derivative","quality_score":30,"revenue":null,"mechanism":""},{"drug_id":"dyclonine","indication_name":"Local anesthesia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Dyclone","generic_name":"DYCLONINE","company_name":"","drug_phase":"marketed","molecular_target":"Acetylcholinesterase","drug_class":"dyclonine","quality_score":40,"revenue":null,"mechanism":""},{"drug_id":"demerol","indication_name":"General anesthesia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Meperidine Hydrochloride Preservative Free","generic_name":"Meperidine Hydrochloride","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Mu-type opioid receptor","drug_class":"Opioid Agonist","quality_score":72,"revenue":null,"mechanism":"Meperidine Hydrochloride Preservative Free works by binding to opioid receptors in the brain, altering the perception of and response to pain."},{"drug_id":"demerol","indication_name":"Local anesthesia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Meperidine Hydrochloride Preservative Free","generic_name":"Meperidine Hydrochloride","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Mu-type opioid receptor","drug_class":"Opioid Agonist","quality_score":72,"revenue":null,"mechanism":"Meperidine Hydrochloride Preservative Free works by binding to opioid receptors in the brain, altering the perception of and response to pain."},{"drug_id":"demerol","indication_name":"Sedation as Adjunct to Anesthesia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Meperidine Hydrochloride Preservative Free","generic_name":"Meperidine Hydrochloride","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Mu-type opioid receptor","drug_class":"Opioid Agonist","quality_score":72,"revenue":null,"mechanism":"Meperidine Hydrochloride Preservative Free works by binding to opioid receptors in the brain, altering the perception of and response to pain."},{"drug_id":"alfentanil","indication_name":"General anesthesia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Alfenta","generic_name":"ALFENTANIL","company_name":"Rising","drug_phase":"marketed","molecular_target":"Mu-type opioid receptor","drug_class":"Opioid Agonist","quality_score":50,"revenue":null,"mechanism":""},{"drug_id":"ephedrine-hydrochloride-3-mg-ml","indication_name":"Treatment of hypotension associated with anesthesia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Ephedrine Hydrochloride 3 MG/ML","company_name":"University Hospital, Ghent","drug_phase":"marketed","molecular_target":"α-adrenergic receptors (α1, α2) and β-adrenergic receptors (β1, β2); sympathetic nerve terminals","drug_class":"Sympathomimetic amine; adrenergic agonist","quality_score":55,"revenue":null,"mechanism":""},{"drug_id":"fospropofol","indication_name":"Sedation as Adjunct to Anesthesia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Lusedra","generic_name":"FOSPROPOFOL","company_name":"","drug_phase":"marketed","molecular_target":"GABA-A receptor","drug_class":"fospropofol","quality_score":24,"revenue":null,"mechanism":""},{"drug_id":"morphine-sulfate","indication_name":"Regional Anesthesia for Labor Pain","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Duramorph Pf","generic_name":"Morphine Sulfate","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Mu-type opioid receptor","drug_class":"Opioid Agonist","quality_score":80,"revenue":null,"mechanism":"Duramorph Pf works by binding to opioid receptors in the brain and spinal cord, mimicking the natural pain-relieving chemicals in the body."},{"drug_id":"morphine-sulfate","indication_name":"Local anesthesia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Duramorph Pf","generic_name":"Morphine Sulfate","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Mu-type opioid receptor","drug_class":"Opioid Agonist","quality_score":80,"revenue":null,"mechanism":"Duramorph Pf works by binding to opioid receptors in the brain and spinal cord, mimicking the natural pain-relieving chemicals in the body."},{"drug_id":"cisatracurium-besylate","indication_name":"General anesthesia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Nimbex","generic_name":"Cisatracurium Besylate","company_name":"AbbVie","drug_phase":"marketed","molecular_target":"Acetylcholine receptor","drug_class":"Nondepolarizing Neuromuscular Blocker","quality_score":80,"revenue":null,"mechanism":"Nimbex works by blocking the action of acetylcholine at the neuromuscular junction, preventing muscle contraction."},{"drug_id":"morphine-sulfate","indication_name":"Regional Anesthesia for Surgery","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Duramorph Pf","generic_name":"Morphine Sulfate","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Mu-type opioid receptor","drug_class":"Opioid Agonist","quality_score":80,"revenue":null,"mechanism":"Duramorph Pf works by binding to opioid receptors in the brain and spinal cord, mimicking the natural pain-relieving chemicals in the body."},{"drug_id":"morphine-sulfate","indication_name":"General anesthesia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Duramorph Pf","generic_name":"Morphine Sulfate","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Mu-type opioid receptor","drug_class":"Opioid Agonist","quality_score":80,"revenue":null,"mechanism":"Duramorph Pf works by binding to opioid receptors in the brain and spinal cord, mimicking the natural pain-relieving chemicals in the body."},{"drug_id":"oxymorphone","indication_name":"General anesthesia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Opana Er","generic_name":"OXYMORPHONE","company_name":"Endo","drug_phase":"marketed","molecular_target":"Mu-type opioid receptor","drug_class":"Opioid Agonist","quality_score":60,"revenue":null,"mechanism":""},{"drug_id":"oxymorphone","indication_name":"Local anesthesia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Opana Er","generic_name":"OXYMORPHONE","company_name":"Endo","drug_phase":"marketed","molecular_target":"Mu-type opioid receptor","drug_class":"Opioid Agonist","quality_score":60,"revenue":null,"mechanism":""},{"drug_id":"isoflurane","indication_name":"General anesthesia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Forane","generic_name":"ISOFLURANE","company_name":"Baxter","drug_phase":"marketed","molecular_target":"5-hydroxytryptamine receptor 2B","drug_class":"General Anesthetic [EPC]","quality_score":60,"revenue":null,"mechanism":""},{"drug_id":"lidocaine-hydrochloride-and-epinephrine","indication_name":"Local anesthesia, by infiltration","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Bupivacaine Hydrochloride And Epinephrine","generic_name":"Epinephrine","company_name":"Pfizer Inc.","drug_phase":"marketed","molecular_target":"Alpha-1D adrenergic receptor","drug_class":"alpha-Adrenergic Agonist [EPC]","quality_score":80,"revenue":null,"mechanism":"Epinephrine works by stimulating the alpha-1D adrenergic receptor to increase heart rate and blood pressure, and to constrict blood vessels."},{"drug_id":"atracurium","indication_name":"General anesthesia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Tracrium Preservative Free","generic_name":"ATRACURIUM","company_name":"","drug_phase":"marketed","molecular_target":"Neuronal acetylcholine receptor subunit alpha-3","drug_class":"Nondepolarizing Neuromuscular Blocker","quality_score":55,"revenue":null,"mechanism":""},{"drug_id":"sufentanil","indication_name":"General anesthesia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Sufenta Preservative Free","generic_name":"SUFENTANIL","company_name":"Rising","drug_phase":"marketed","molecular_target":"Mu-type opioid receptor","drug_class":"Opioid Agonist","quality_score":80,"revenue":null,"mechanism":"Sufentanil works by binding to opioid receptors in the brain, spinal cord, and other areas to produce pain relief."},{"drug_id":"amidate","indication_name":"Induction of general anesthesia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Amidate","generic_name":"Etomidate","company_name":"Pfizer Inc.","drug_phase":"marketed","molecular_target":"GABA A receptor alpha-2/beta-2/gamma-2","drug_class":"General Anesthetic [EPC]","quality_score":60,"revenue":null,"mechanism":""},{"drug_id":"amidate","indication_name":"Supplementation of subpotent anesthetic agents during maintenance of anesthesia for short operative procedures","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Amidate","generic_name":"Etomidate","company_name":"Pfizer Inc.","drug_phase":"marketed","molecular_target":"GABA A receptor alpha-2/beta-2/gamma-2","drug_class":"General Anesthetic [EPC]","quality_score":60,"revenue":null,"mechanism":""},{"drug_id":"amidate","indication_name":"Supplementation of nitrous oxide in oxygen during maintenance of anesthesia for dilation and curettage","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Amidate","generic_name":"Etomidate","company_name":"Pfizer Inc.","drug_phase":"marketed","molecular_target":"GABA A receptor alpha-2/beta-2/gamma-2","drug_class":"General Anesthetic [EPC]","quality_score":60,"revenue":null,"mechanism":""},{"drug_id":"amidate","indication_name":"Supplementation of nitrous oxide in oxygen during maintenance of anesthesia for cervical conization","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Amidate","generic_name":"Etomidate","company_name":"Pfizer Inc.","drug_phase":"marketed","molecular_target":"GABA A receptor alpha-2/beta-2/gamma-2","drug_class":"General Anesthetic [EPC]","quality_score":60,"revenue":null,"mechanism":""},{"drug_id":"chloroprocaine","indication_name":"Local anesthesia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Nesacaine-Mpf","generic_name":"CHLOROPROCAINE","company_name":"Fresenius Kabi","drug_phase":"marketed","molecular_target":"Sodium channel protein type 10 subunit alpha","drug_class":"Ester Local Anesthetic","quality_score":39,"revenue":null,"mechanism":""},{"drug_id":"benzalkonium","indication_name":"Local anesthesia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Benzododecinium","generic_name":"BENZALKONIUM","company_name":"","drug_phase":"marketed","molecular_target":"","drug_class":"benzalkonium","quality_score":35,"revenue":null,"mechanism":""},{"drug_id":"benzocaine","indication_name":"Local anesthesia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Norcaine","generic_name":"BENZOCAINE","company_name":"","drug_phase":"marketed","molecular_target":"Sodium channel protein type 5 subunit alpha","drug_class":"Standardized Chemical Allergen [EPC]","quality_score":23,"revenue":null,"mechanism":""},{"drug_id":"doxacurium","indication_name":"General anesthesia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Bw-A938U","generic_name":"DOXACURIUM","company_name":"","drug_phase":"marketed","molecular_target":"Acetylcholine receptor","drug_class":"doxacurium","quality_score":40,"revenue":null,"mechanism":""},{"drug_id":"levobupivacaine","indication_name":"Anesthesia for cesarean section","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Chirocain","generic_name":"LEVOBUPIVACAINE","company_name":"Purdue Pharma Lp","drug_phase":"marketed","molecular_target":"Cytochrome P450 2D6","drug_class":"levobupivacaine","quality_score":40,"revenue":null,"mechanism":""},{"drug_id":"levobupivacaine","indication_name":"Local anesthesia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Chirocain","generic_name":"LEVOBUPIVACAINE","company_name":"Purdue Pharma Lp","drug_phase":"marketed","molecular_target":"Cytochrome P450 2D6","drug_class":"levobupivacaine","quality_score":40,"revenue":null,"mechanism":""},{"drug_id":"levobupivacaine","indication_name":"Regional Anesthesia for Labor Pain","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Chirocain","generic_name":"LEVOBUPIVACAINE","company_name":"Purdue Pharma Lp","drug_phase":"marketed","molecular_target":"Cytochrome P450 2D6","drug_class":"levobupivacaine","quality_score":40,"revenue":null,"mechanism":""},{"drug_id":"levobupivacaine","indication_name":"Regional Anesthesia for Postoperative Pain","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Chirocain","generic_name":"LEVOBUPIVACAINE","company_name":"Purdue Pharma Lp","drug_phase":"marketed","molecular_target":"Cytochrome P450 2D6","drug_class":"levobupivacaine","quality_score":40,"revenue":null,"mechanism":""},{"drug_id":"levobupivacaine","indication_name":"Regional Anesthesia for Surgery","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Chirocain","generic_name":"LEVOBUPIVACAINE","company_name":"Purdue Pharma Lp","drug_phase":"marketed","molecular_target":"Cytochrome P450 2D6","drug_class":"levobupivacaine","quality_score":40,"revenue":null,"mechanism":""},{"drug_id":"amobarbital","indication_name":"General anesthesia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Amobarbitone","generic_name":"AMOBARBITAL","company_name":"","drug_phase":"marketed","molecular_target":"","drug_class":"amobarbital","quality_score":28,"revenue":null,"mechanism":""},{"drug_id":"amobarbital","indication_name":"Local anesthesia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Amobarbitone","generic_name":"AMOBARBITAL","company_name":"","drug_phase":"marketed","molecular_target":"","drug_class":"amobarbital","quality_score":28,"revenue":null,"mechanism":""},{"drug_id":"pentobarbital","indication_name":"General anesthesia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Nembutal Sodium","generic_name":"PENTOBARBITAL","company_name":"Oak Pharms","drug_phase":"marketed","molecular_target":"GABA-A receptor alpha-1/beta-2/gamma-2","drug_class":"pentobarbital","quality_score":45,"revenue":null,"mechanism":""},{"drug_id":"pentobarbital","indication_name":"Local anesthesia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Nembutal Sodium","generic_name":"PENTOBARBITAL","company_name":"Oak Pharms","drug_phase":"marketed","molecular_target":"GABA-A receptor alpha-1/beta-2/gamma-2","drug_class":"pentobarbital","quality_score":45,"revenue":null,"mechanism":""},{"drug_id":"ketamine","indication_name":"General anesthesia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Ketalar","generic_name":"ketamine","company_name":"Ph Health","drug_phase":"marketed","molecular_target":"Glutamate [NMDA] receptor","drug_class":"General Anesthetic","quality_score":75,"revenue":null,"mechanism":"Ketamine works by blocking the action of glutamate at the NMDA receptor, which is involved in pain perception and memory formation."},{"drug_id":"ketamine","indication_name":"Local anesthesia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Ketalar","generic_name":"ketamine","company_name":"Ph Health","drug_phase":"marketed","molecular_target":"Glutamate [NMDA] receptor","drug_class":"General Anesthetic","quality_score":75,"revenue":null,"mechanism":"Ketamine works by blocking the action of glutamate at the NMDA receptor, which is involved in pain perception and memory formation."},{"drug_id":"mephentermine","indication_name":"Hypotension Secondary to Spinal Anesthesia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Vialin","generic_name":"MEPHENTERMINE","company_name":"Baxter","drug_phase":"marketed","molecular_target":"Alpha-1A adrenergic receptor","drug_class":"Indirectly Acting Sympathomimetic Amines","quality_score":35,"revenue":null,"mechanism":""},{"drug_id":"mephentermine","indication_name":"Prevention of Hypotension During Spinal Anesthesia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Vialin","generic_name":"MEPHENTERMINE","company_name":"Baxter","drug_phase":"marketed","molecular_target":"Alpha-1A adrenergic receptor","drug_class":"Indirectly Acting Sympathomimetic Amines","quality_score":35,"revenue":null,"mechanism":""},{"drug_id":"cysteine","indication_name":"General anesthesia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Cysteine Hydrochloride","generic_name":"CYSTEINE","company_name":"Exela Pharma","drug_phase":"marketed","molecular_target":"Cystine/glutamate transporter","drug_class":"Vitamin C [EPC]","quality_score":50,"revenue":null,"mechanism":""},{"drug_id":"methohexital","indication_name":"General anesthesia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Brevital Sodium","generic_name":"METHOHEXITAL","company_name":"Ph Health","drug_phase":"marketed","molecular_target":"GABA-A receptor alpha-1/beta-3/gamma-2","drug_class":"Barbiturate","quality_score":50,"revenue":null,"mechanism":""},{"drug_id":"methohexital","indication_name":"Local anesthesia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Brevital Sodium","generic_name":"METHOHEXITAL","company_name":"Ph Health","drug_phase":"marketed","molecular_target":"GABA-A receptor alpha-1/beta-3/gamma-2","drug_class":"Barbiturate","quality_score":50,"revenue":null,"mechanism":""},{"drug_id":"flumazenil","indication_name":"Benzodiazepine Maintained Anesthesia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Romazicon","generic_name":"FLUMAZENIL","company_name":"","drug_phase":"marketed","molecular_target":"Gamma-aminobutyric acid receptor subunit alpha-5","drug_class":"Benzodiazepine Antagonist [EPC]","quality_score":51,"revenue":null,"mechanism":""},{"drug_id":"propofol","indication_name":"General anesthesia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Diprivan","generic_name":"Propofol","company_name":"Fresenius Kabi","drug_phase":"marketed","molecular_target":"GABA A receptors","drug_class":"General anesthetic","quality_score":77,"revenue":null,"mechanism":"Propofol produces sedative/anesthetic effects by positive modulation of inhibitory GABA function through GABA A receptors."},{"drug_id":"propofol","indication_name":"Sedation as Adjunct to Anesthesia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Diprivan","generic_name":"Propofol","company_name":"Fresenius Kabi","drug_phase":"marketed","molecular_target":"GABA A receptors","drug_class":"General anesthetic","quality_score":77,"revenue":null,"mechanism":"Propofol produces sedative/anesthetic effects by positive modulation of inhibitory GABA function through GABA A receptors."},{"drug_id":"halothane","indication_name":"General anesthesia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Anestan","generic_name":"HALOTHANE","company_name":"","drug_phase":"marketed","molecular_target":"GABA-A receptor; anion channel","drug_class":"halothane","quality_score":35,"revenue":null,"mechanism":""},{"drug_id":"thiopental","indication_name":"General anesthesia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Pentothal","generic_name":"THIOPENTAL","company_name":"Abbott","drug_phase":"marketed","molecular_target":"GABA-A receptor alpha-1/beta-2/gamma-2","drug_class":"thiopental","quality_score":30,"revenue":null,"mechanism":""},{"drug_id":"butorphanol","indication_name":"General anesthesia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Stadol Preservative Free","generic_name":"BUTORPHANOL","company_name":"","drug_phase":"marketed","molecular_target":"Kappa-type opioid receptor","drug_class":"Opioid Agonist/Antagonist","quality_score":57,"revenue":null,"mechanism":""},{"drug_id":"butorphanol","indication_name":"Sedation as Adjunct to Anesthesia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Stadol Preservative Free","generic_name":"BUTORPHANOL","company_name":"","drug_phase":"marketed","molecular_target":"Kappa-type opioid receptor","drug_class":"Opioid Agonist/Antagonist","quality_score":57,"revenue":null,"mechanism":""},{"drug_id":"tetracaine","indication_name":"Administration of Corneal Anesthesia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Tetracaine Hydrochloride","generic_name":"TETRACAINE","company_name":"Alcon Labs","drug_phase":"marketed","molecular_target":"Sodium channel protein type 7 subunit alpha","drug_class":"Ester Local Anesthetic","quality_score":70,"revenue":null,"mechanism":"Tetracaine Hydrochloride works by blocking sodium channels in nerve cells to prevent pain signals from being transmitted."},{"drug_id":"tetracaine","indication_name":"Local Anesthesia for Ophthalmologic Procedure","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Tetracaine Hydrochloride","generic_name":"TETRACAINE","company_name":"Alcon Labs","drug_phase":"marketed","molecular_target":"Sodium channel protein type 7 subunit alpha","drug_class":"Ester Local Anesthetic","quality_score":70,"revenue":null,"mechanism":"Tetracaine Hydrochloride works by blocking sodium channels in nerve cells to prevent pain signals from being transmitted."},{"drug_id":"tetracaine","indication_name":"Local anesthesia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Tetracaine Hydrochloride","generic_name":"TETRACAINE","company_name":"Alcon Labs","drug_phase":"marketed","molecular_target":"Sodium channel protein type 7 subunit alpha","drug_class":"Ester Local Anesthetic","quality_score":70,"revenue":null,"mechanism":"Tetracaine Hydrochloride works by blocking sodium channels in nerve cells to prevent pain signals from being transmitted."},{"drug_id":"desf","indication_name":"General anesthesia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"DESF","company_name":"Baxter Hlthcare","drug_phase":"marketed","molecular_target":"Potassium channel subfamily K member 10, Potassium channel subfamily K member 18, Potassium channel subfamily K member 2","drug_class":"","quality_score":null,"revenue":null,"mechanism":"Desf works by interacting with a specific biological target to produce a therapeutic effect."},{"drug_id":"chlorprocaine","indication_name":"Local anesthesia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Chlorprocaine","company_name":"Hadassah Medical Organization","drug_phase":"marketed","molecular_target":"Sodium channel protein type 10 subunit alpha","drug_class":"","quality_score":null,"revenue":null,"mechanism":null},{"drug_id":"lusedra","indication_name":"Sedation as Adjunct to Anesthesia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Lusedra","company_name":"Eisai Inc.","drug_phase":"phase_1","molecular_target":"GABA-A receptor","drug_class":"","quality_score":null,"revenue":null,"mechanism":null},{"drug_id":"epinephrin","indication_name":"Local anesthesia, by infiltration","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Epinephrin","company_name":"United States Naval Medical Center, San Diego","drug_phase":"marketed","molecular_target":"Alpha-1A adrenergic receptor, Alpha-1B adrenergic receptor, Alpha-1D adrenergic receptor","drug_class":"","quality_score":null,"revenue":null,"mechanism":null},{"drug_id":"carbocaine","indication_name":"Administration of Regional Anesthesia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Carbocaine","company_name":"Nantes University Hospital","drug_phase":"marketed","molecular_target":"Sodium channel protein type 1 subunit alpha, Sodium channel protein type 2 subunit alpha, Sodium channel protein type 3 subunit alpha","drug_class":"","quality_score":null,"revenue":null,"mechanism":null},{"drug_id":"carbocaine","indication_name":"Local anesthesia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Carbocaine","company_name":"Nantes University Hospital","drug_phase":"marketed","molecular_target":"Sodium channel protein type 1 subunit alpha, Sodium channel protein type 2 subunit alpha, Sodium channel protein type 3 subunit alpha","drug_class":"","quality_score":null,"revenue":null,"mechanism":null},{"drug_id":"carbocaine","indication_name":"Local anesthesia, by infiltration","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Carbocaine","company_name":"Nantes University Hospital","drug_phase":"marketed","molecular_target":"Sodium channel protein type 1 subunit alpha, Sodium channel protein type 2 subunit alpha, Sodium channel protein type 3 subunit alpha","drug_class":"","quality_score":null,"revenue":null,"mechanism":null},{"drug_id":"lidocain","indication_name":"Local Anesthesia for Endotracheal Intubation","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Lidocain","company_name":"Bayer","drug_phase":"marketed","molecular_target":"5-hydroxytryptamine receptor 3A, Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 4, Sodium channel protein type 10 subunit alpha","drug_class":"","quality_score":null,"revenue":null,"mechanism":null},{"drug_id":"lidocain","indication_name":"Local Anesthesia for Ophthalmologic Procedure","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Lidocain","company_name":"Bayer","drug_phase":"marketed","molecular_target":"5-hydroxytryptamine receptor 3A, Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 4, Sodium channel protein type 10 subunit alpha","drug_class":"","quality_score":null,"revenue":null,"mechanism":null},{"drug_id":"lidocain","indication_name":"Local Anesthesia for Urethral Pain","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Lidocain","company_name":"Bayer","drug_phase":"marketed","molecular_target":"5-hydroxytryptamine receptor 3A, Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 4, Sodium channel protein type 10 subunit alpha","drug_class":"","quality_score":null,"revenue":null,"mechanism":null},{"drug_id":"lidocain","indication_name":"Local anesthesia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Lidocain","company_name":"Bayer","drug_phase":"marketed","molecular_target":"5-hydroxytryptamine receptor 3A, Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 4, Sodium channel protein type 10 subunit alpha","drug_class":"","quality_score":null,"revenue":null,"mechanism":null},{"drug_id":"lidocain","indication_name":"Regional Anesthesia for Ophthalmologic Surgery","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Lidocain","company_name":"Bayer","drug_phase":"marketed","molecular_target":"5-hydroxytryptamine receptor 3A, Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 4, Sodium channel protein type 10 subunit alpha","drug_class":"","quality_score":null,"revenue":null,"mechanism":null},{"drug_id":"methohexitone","indication_name":"General anesthesia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Methohexitone","company_name":"St Patrick's Hospital, Ireland","drug_phase":"marketed","molecular_target":"Neuronal acetylcholine receptor; alpha2/beta2, Glycine receptor subunit alpha-1, GABA-A receptor alpha-1/beta-3/gamma-2","drug_class":"","quality_score":null,"revenue":null,"mechanism":null},{"drug_id":"methohexitone","indication_name":"Local anesthesia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Methohexitone","company_name":"St Patrick's Hospital, Ireland","drug_phase":"marketed","molecular_target":"Neuronal acetylcholine receptor; alpha2/beta2, Glycine receptor subunit alpha-1, GABA-A receptor alpha-1/beta-3/gamma-2","drug_class":"","quality_score":null,"revenue":null,"mechanism":null},{"drug_id":"sialanar","indication_name":"General anesthesia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Sialanar","company_name":"Proveca Pharma Limited","drug_phase":"marketed","molecular_target":"Muscarinic acetylcholine receptor M1, Muscarinic acetylcholine receptor M2, Muscarinic acetylcholine receptor M3","drug_class":"","quality_score":null,"revenue":null,"mechanism":null},{"drug_id":"proxymetacaine","indication_name":"Administration of Corneal Anesthesia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Proxymetacaine","company_name":"Medical University of Silesia","drug_phase":"phase_1","molecular_target":"Amine oxidase [flavin-containing] A, Sigma non-opioid intracellular receptor 1, Sodium channel protein type 10 subunit alpha","drug_class":"","quality_score":null,"revenue":null,"mechanism":null},{"drug_id":"proxymetacaine","indication_name":"Local Anesthesia for Ophthalmologic Procedure","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Proxymetacaine","company_name":"Medical University of Silesia","drug_phase":"phase_1","molecular_target":"Amine oxidase [flavin-containing] A, Sigma non-opioid intracellular receptor 1, Sodium channel protein type 10 subunit alpha","drug_class":"","quality_score":null,"revenue":null,"mechanism":null},{"drug_id":"sevorane","indication_name":"General anesthesia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"sevorane","company_name":"University Hospital, Ghent","drug_phase":"marketed","molecular_target":"Glycine receptor subunit alpha-1, Potassium channel subfamily K member 10, Potassium channel subfamily K member 18","drug_class":"","quality_score":null,"revenue":null,"mechanism":null},{"drug_id":"succinylcholine","indication_name":"General anesthesia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Succinylcholine","company_name":"Charles University, Czech Republic","drug_phase":"marketed","molecular_target":"Muscle-type nicotinic acetylcholine receptor, Acetylcholinesterase","drug_class":"","quality_score":null,"revenue":null,"mechanism":null},{"drug_id":"sulfentanil","indication_name":"General anesthesia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Sulfentanil","company_name":"Henan Provincial People's Hospital","drug_phase":"phase_1","molecular_target":"Solute carrier family 22 member 1, Delta-type opioid receptor, Kappa-type opioid receptor","drug_class":"","quality_score":null,"revenue":null,"mechanism":null},{"drug_id":"xylocain","indication_name":"Local Anesthesia for Endotracheal Intubation","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"xylocain","company_name":"Saint-Joseph University","drug_phase":"marketed","molecular_target":"5-hydroxytryptamine receptor 3A, Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 4, Sodium channel protein type 10 subunit alpha","drug_class":"","quality_score":null,"revenue":null,"mechanism":null},{"drug_id":"xylocain","indication_name":"Local Anesthesia for Ophthalmologic Procedure","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"xylocain","company_name":"Saint-Joseph University","drug_phase":"marketed","molecular_target":"5-hydroxytryptamine receptor 3A, Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 4, Sodium channel protein type 10 subunit alpha","drug_class":"","quality_score":null,"revenue":null,"mechanism":null},{"drug_id":"xylocain","indication_name":"Local Anesthesia for Urethral Pain","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"xylocain","company_name":"Saint-Joseph University","drug_phase":"marketed","molecular_target":"5-hydroxytryptamine receptor 3A, Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 4, Sodium channel protein type 10 subunit alpha","drug_class":"","quality_score":null,"revenue":null,"mechanism":null},{"drug_id":"xylocain","indication_name":"Local anesthesia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"xylocain","company_name":"Saint-Joseph University","drug_phase":"marketed","molecular_target":"5-hydroxytryptamine receptor 3A, Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 4, Sodium channel protein type 10 subunit alpha","drug_class":"","quality_score":null,"revenue":null,"mechanism":null},{"drug_id":"xylocain","indication_name":"Regional Anesthesia for Ophthalmologic Surgery","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"xylocain","company_name":"Saint-Joseph University","drug_phase":"marketed","molecular_target":"5-hydroxytryptamine receptor 3A, Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 4, Sodium channel protein type 10 subunit alpha","drug_class":"","quality_score":null,"revenue":null,"mechanism":null},{"drug_id":"bupivacaine-hydrochloride-and-epinephrine","indication_name":"Anesthesia for cesarean section","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Bupivacaine Hydrochloride","generic_name":"Bupivacaine Hydrochloride","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Nerve sodium channels","drug_class":"Amide-type local anesthetic","quality_score":70,"revenue":null,"mechanism":"Bupivacaine blocks nerve impulse generation and conduction by increasing electrical excitation threshold and slowing action potential rise."},{"drug_id":"bupivacaine-hydrochloride-and-epinephrine","indication_name":"Local Anesthesia for Ophthalmologic Procedure","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Bupivacaine Hydrochloride","generic_name":"Bupivacaine Hydrochloride","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Nerve sodium channels","drug_class":"Amide-type local anesthetic","quality_score":70,"revenue":null,"mechanism":"Bupivacaine blocks nerve impulse generation and conduction by increasing electrical excitation threshold and slowing action potential rise."},{"drug_id":"bupivacaine-hydrochloride-and-epinephrine","indication_name":"Local anesthesia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Bupivacaine Hydrochloride","generic_name":"Bupivacaine Hydrochloride","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Nerve sodium channels","drug_class":"Amide-type local anesthetic","quality_score":70,"revenue":null,"mechanism":"Bupivacaine blocks nerve impulse generation and conduction by increasing electrical excitation threshold and slowing action potential rise."},{"drug_id":"bupivacaine-hydrochloride-and-epinephrine","indication_name":"Regional Anesthesia for Labor Pain","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Bupivacaine Hydrochloride","generic_name":"Bupivacaine Hydrochloride","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Nerve sodium channels","drug_class":"Amide-type local anesthetic","quality_score":70,"revenue":null,"mechanism":"Bupivacaine blocks nerve impulse generation and conduction by increasing electrical excitation threshold and slowing action potential rise."},{"drug_id":"bupivacaine-hydrochloride-and-epinephrine","indication_name":"Regional Anesthesia for Ophthalmologic Surgery","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Bupivacaine Hydrochloride","generic_name":"Bupivacaine Hydrochloride","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Nerve sodium channels","drug_class":"Amide-type local anesthetic","quality_score":70,"revenue":null,"mechanism":"Bupivacaine blocks nerve impulse generation and conduction by increasing electrical excitation threshold and slowing action potential rise."},{"drug_id":"bupivacaine-hydrochloride-and-epinephrine","indication_name":"Regional Anesthesia for Postoperative Pain","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Bupivacaine Hydrochloride","generic_name":"Bupivacaine Hydrochloride","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Nerve sodium channels","drug_class":"Amide-type local anesthetic","quality_score":70,"revenue":null,"mechanism":"Bupivacaine blocks nerve impulse generation and conduction by increasing electrical excitation threshold and slowing action potential rise."},{"drug_id":"bupivacaine-hydrochloride-and-epinephrine","indication_name":"Regional Anesthesia for Surgery","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Bupivacaine Hydrochloride","generic_name":"Bupivacaine Hydrochloride","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Nerve sodium channels","drug_class":"Amide-type local anesthetic","quality_score":70,"revenue":null,"mechanism":"Bupivacaine blocks nerve impulse generation and conduction by increasing electrical excitation threshold and slowing action potential rise."}],"pipeline":[],"offLabel":[],"totalMarketed":214,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT07022951","title":"The Million Anesthesia Cases Study (MACS) - a Cohort Study of Preoperative Fasting and Perioperative Outcomes","phase":"","overall_status":"RECRUITING","enrollment_count":1200000,"lead_sponsor_name":"Massachusetts General Hospital","has_results":false},{"nct_id":"NCT04389008","title":"The Study of Anesthesia-related Risk Factors for Postoperative Death in Elderly Non-cardiac Surgery Patients in China","phase":"","overall_status":"UNKNOWN","enrollment_count":300000,"lead_sponsor_name":"Chinese PLA General Hospital","has_results":false},{"nct_id":"NCT05471882","title":"Predicting Neuromuscular Recovery in Surgical Patients Using Machine Learning","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":240000,"lead_sponsor_name":"University Hospital Ulm","has_results":false},{"nct_id":"NCT02914444","title":"Registry Construction of Intraoperative Vital Signs and Clinical Information in Surgical Patients","phase":"","overall_status":"UNKNOWN","enrollment_count":200000,"lead_sponsor_name":"Seoul National University Hospital","has_results":false},{"nct_id":"NCT06146270","title":"Russian Registry of Surgical OutcomeS","phase":"","overall_status":"RECRUITING","enrollment_count":162000,"lead_sponsor_name":"Russian Federation of Anesthesiologists and Reanimatologists","has_results":false},{"nct_id":"NCT04047329","title":"Risk Factors and Impact of Anesthesia Techniques on Myocardial Infarction Following Transurethral Resection of the Prostate","phase":"","overall_status":"COMPLETED","enrollment_count":115025,"lead_sponsor_name":"Chang Gung Memorial Hospital","has_results":false},{"nct_id":"NCT06948409","title":"NMBA Reversal and Postoperative Urinary Retention","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":70000,"lead_sponsor_name":"Beth Israel Deaconess Medical Center","has_results":false},{"nct_id":"NCT06582407","title":"Machine Learning Models for Predicting Unforeseen Hospital Admissions or Discharges After Anesthesia","phase":"","overall_status":"COMPLETED","enrollment_count":68683,"lead_sponsor_name":"HUmani","has_results":false},{"nct_id":"NCT06403163","title":"Transfusion Surveillance in Anaesthesia","phase":"","overall_status":"RECRUITING","enrollment_count":50000,"lead_sponsor_name":"Erasme University Hospital","has_results":false},{"nct_id":"NCT03335579","title":"General Anesthetic Mode and Postoperative Complications","phase":"","overall_status":"COMPLETED","enrollment_count":50000,"lead_sponsor_name":"Peking University First Hospital","has_results":false},{"nct_id":"NCT03971851","title":"Validation of a Novel Frailty Index in Surgical Cohorts","phase":"","overall_status":"COMPLETED","enrollment_count":50000,"lead_sponsor_name":"University of Iceland","has_results":false},{"nct_id":"NCT06617403","title":"Pre-operative Characteristics for Prediction of Supraglottic Airway Failure Using Machine Learning (ERICA)","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":44000,"lead_sponsor_name":"University Hospital Ulm","has_results":false},{"nct_id":"NCT05706688","title":"Effect of Regional Versus General Anesthesia on Thirty-day Outcomes Following Carotid Endarterectomy: a Matched-pairs Cohort Study.","phase":"","overall_status":"COMPLETED","enrollment_count":37204,"lead_sponsor_name":"University of Virginia","has_results":false},{"nct_id":"NCT04014010","title":"Machine Learning Modeling of Intraoperative Hemodynamic Predictors of Postoperative Outcomes","phase":"","overall_status":"COMPLETED","enrollment_count":35000,"lead_sponsor_name":"Janny Xue Chen Ke","has_results":false},{"nct_id":"NCT04697732","title":"İntraoperative Awareness Under General Anesthesia","phase":"","overall_status":"UNKNOWN","enrollment_count":30000,"lead_sponsor_name":"Baskent University Ankara Hospital","has_results":false},{"nct_id":"NCT05579808","title":"Effect of Epidural Analgesia on Labour, Neonatal and Maternal Outcomes.","phase":"","overall_status":"COMPLETED","enrollment_count":21808,"lead_sponsor_name":"Fondazione Policlinico Universitario Agostino Gemelli IRCCS","has_results":false},{"nct_id":"NCT07136194","title":"Risk Factors of Postoperative Acute Kidney Injury and Mortality Among Hospitalized Patients Undergoing Major Surgery","phase":"","overall_status":"COMPLETED","enrollment_count":21533,"lead_sponsor_name":"Peking University First Hospital","has_results":false},{"nct_id":"NCT06298435","title":"Optimising Ventilatory Strategies by Using Positive Respiratory Integer Measurements","phase":"","overall_status":"UNKNOWN","enrollment_count":20000,"lead_sponsor_name":"University Medical Center Groningen","has_results":false},{"nct_id":"NCT05046925","title":"PACU for Postoperative Care After Major Thoracic and Abdominal Surgery","phase":"","overall_status":"UNKNOWN","enrollment_count":18000,"lead_sponsor_name":"First Affiliated Hospital of Zhejiang University","has_results":false},{"nct_id":"NCT04451642","title":"A Retrospective Clinical Registry of Peripheral Nerve Block","phase":"","overall_status":"COMPLETED","enrollment_count":13816,"lead_sponsor_name":"Instituto de Investigación Sanitaria Aragón","has_results":false},{"nct_id":"NCT05991453","title":"Trajectories of Recovery After Intravenous Propofol Versus Inhaled VolatilE Anesthesia Trial","phase":"NA","overall_status":"RECRUITING","enrollment_count":13000,"lead_sponsor_name":"Washington University School of Medicine","has_results":false},{"nct_id":"NCT04256798","title":"Perioperative Respiratory Care and Outcomes for Patients Undergoing High Risk Abdominal Surgery","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":12942,"lead_sponsor_name":"University of Birmingham","has_results":false},{"nct_id":"NCT04203732","title":"Evaluation of Anesthetic Techniques in Outpatient Total Joint Replacement Surgery in an Integrated Health Care Delivery System","phase":"","overall_status":"COMPLETED","enrollment_count":12466,"lead_sponsor_name":"Kaiser Permanente","has_results":false},{"nct_id":"NCT04837170","title":"Safety and Efficacy Evaluation of S (+) - Ketamine in Adults","phase":"PHASE4","overall_status":"UNKNOWN","enrollment_count":12000,"lead_sponsor_name":"Chinese PLA General Hospital","has_results":false},{"nct_id":"NCT06396000","title":"Factors Analysis Related to Prolonged Stay in the Pediatric Post-Anesthesia Care Unit(PACU)","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":10000,"lead_sponsor_name":"Saiqiang Guo","has_results":false},{"nct_id":"NCT05869578","title":"Registry of Anesthesia and Perioperative Medicine","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":10000,"lead_sponsor_name":"Clinica Alemana de Santiago","has_results":false},{"nct_id":"NCT04362709","title":"Study of Post-anesthesia Management in Patients Undergoing Neurosurgery","phase":"","overall_status":"RECRUITING","enrollment_count":10000,"lead_sponsor_name":"Beijing Tiantan Hospital","has_results":false},{"nct_id":"NCT05934682","title":"Latin American Surgical Outcomes Study in Pediatric Patients","phase":"","overall_status":"RECRUITING","enrollment_count":10000,"lead_sponsor_name":"University of Sao Paulo","has_results":false},{"nct_id":"NCT05277441","title":"A Novel Classification for the Assessment and Grading of Unexpected Events in Pediatric Surgery: The Clavien-Madadi Classification","phase":"","overall_status":"UNKNOWN","enrollment_count":10000,"lead_sponsor_name":"Hannover Medical School","has_results":false},{"nct_id":"NCT04730310","title":"Anesthesia Technique and Lower Limb Revascularization Patency","phase":"","overall_status":"COMPLETED","enrollment_count":8893,"lead_sponsor_name":"University of British Columbia","has_results":false},{"nct_id":"NCT05728775","title":"REmimazolam vs Propofol Total Intravenous Anesthesia on Outcomes After Major Noncardiac SurgEry","phase":"PHASE4","overall_status":"RECRUITING","enrollment_count":7188,"lead_sponsor_name":"Nanfang Hospital, Southern Medical University","has_results":false},{"nct_id":"NCT07259629","title":"Fasting Induced Hypoglycaemia in Anaesthetised Paediatric Patients","phase":"","overall_status":"RECRUITING","enrollment_count":6580,"lead_sponsor_name":"Guy's and St Thomas' NHS Foundation Trust","has_results":false},{"nct_id":"NCT05788718","title":"An Observational Study to Analyze the Prescription Pattern of Sugammadex and Its Effectiveness and Safety","phase":"","overall_status":"COMPLETED","enrollment_count":6458,"lead_sponsor_name":"Boryung Pharmaceutical Co., Ltd","has_results":false},{"nct_id":"NCT07495436","title":"Video Versus Direct Laryngoscopy for Tracheal Intubation in Pediatric Surgery","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":5562,"lead_sponsor_name":"Hospital Clinico Universitario de Santiago","has_results":false},{"nct_id":"NCT04493905","title":"Effects of Anesthetic Techniques on Time to Start of Adjuvant Chemotherapy Following Surgery for Colorectal Cancer","phase":"","overall_status":"COMPLETED","enrollment_count":5500,"lead_sponsor_name":"European Society of Anaesthesiology","has_results":false},{"nct_id":"NCT06330038","title":"Anesthesia and Non-small Cell Lung Cancer Recurrence","phase":"PHASE4","overall_status":"NOT_YET_RECRUITING","enrollment_count":5384,"lead_sponsor_name":"Samsung Medical Center","has_results":false},{"nct_id":"NCT05762237","title":"Deep Learning Models for Prediction of Intraoperative Hypotension Using Non-invasive Parameters","phase":"","overall_status":"COMPLETED","enrollment_count":5175,"lead_sponsor_name":"Samsung Medical Center","has_results":false},{"nct_id":"NCT03111875","title":"Perioperative Hypothermia and Myocardial Injury After Non-cardiac Surgery","phase":"NA","overall_status":"COMPLETED","enrollment_count":5056,"lead_sponsor_name":"The Cleveland Clinic","has_results":true},{"nct_id":"NCT04912791","title":"Obstetric Anaesthesia And Analgesia Month Attributes - in COVID-19","phase":"","overall_status":"UNKNOWN","enrollment_count":5000,"lead_sponsor_name":"Brno University Hospital","has_results":false},{"nct_id":"NCT05026788","title":"Impact of COVID-19 Pandemic on Orthopaedic Practice","phase":"","overall_status":"UNKNOWN","enrollment_count":5000,"lead_sponsor_name":"Imperial College Healthcare NHS Trust","has_results":false},{"nct_id":"NCT06460792","title":"Ultrasound-guided Peripheral Nerve Blocks - a Database","phase":"","overall_status":"RECRUITING","enrollment_count":5000,"lead_sponsor_name":"Nordsjaellands Hospital","has_results":false},{"nct_id":"NCT06160583","title":"General Anesthesia for Cesarean Section, Maternal and Perinatal Outcomes","phase":"","overall_status":"COMPLETED","enrollment_count":5000,"lead_sponsor_name":"Hospital Civil de Guadalajara","has_results":false},{"nct_id":"NCT05671783","title":"Intraoperative Hypotension and Post-anesthesia Care Unit Recovery","phase":"","overall_status":"COMPLETED","enrollment_count":4776,"lead_sponsor_name":"Acibadem University","has_results":false},{"nct_id":"NCT03770364","title":"Peri-operative Hypothermia in Children","phase":"","overall_status":"COMPLETED","enrollment_count":4500,"lead_sponsor_name":"KK Women's and Children's Hospital","has_results":false},{"nct_id":"NCT06084039","title":"Reducing the Carbon Footprint Through Education on the Effects of Inhalation Anesthetics on Global Warming","phase":"","overall_status":"COMPLETED","enrollment_count":4478,"lead_sponsor_name":"Pusan National University Yangsan Hospital","has_results":false},{"nct_id":"NCT05689840","title":"Association Between Post-covid Infection Status and Perioperative Morbidity: A Ambispective Cohort Study","phase":"","overall_status":"COMPLETED","enrollment_count":4000,"lead_sponsor_name":"Peking Union Medical College Hospital","has_results":false},{"nct_id":"NCT04789330","title":"Norepinephrine vs Phenylephrine During General Anesthesia","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":3626,"lead_sponsor_name":"University of California, San Francisco","has_results":true},{"nct_id":"NCT06656793","title":"Impact of Real-Time Ultrasound-Guided Spinal Anesthesia Versus Landmark-Guided Spinal Anesthesia on Anesthesia Procedural Time","phase":"","overall_status":"COMPLETED","enrollment_count":3597,"lead_sponsor_name":"Tongji Hospital","has_results":false},{"nct_id":"NCT07238933","title":"Neurological Events and Unforeseen Risks After Locoregional-anesthesia","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":3396,"lead_sponsor_name":"Societa Italiana Anestesia Analgesia Rianimazione e Terapia Intensiva","has_results":false},{"nct_id":"NCT03597932","title":"Intraoperative Handover Checklist of Anesthesia Care Improves Outcomes Among Patients Undergoing Major Surgery","phase":"","overall_status":"UNKNOWN","enrollment_count":3342,"lead_sponsor_name":"First Affiliated Hospital of Zhejiang University","has_results":false}],"total":50},"guidelines":[],"source":"Drug Landscape verified database"}